JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Middlemas, D. S.
Right arrow Articles by Zhu, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Middlemas, D. S.
Right arrow Articles by Zhu, X.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 23, 16451-16460, June 4, 1999

Brain-derived Neurotrophic Factor Promotes Survival and Chemoprotection of Human Neuroblastoma Cells

David S. Middlemas, Brenda K. Kihl, Junfang Zhou, and Xiaoyan Zhu

From the Department of Molecular Pharmacology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105-2794

Brain-derived neurotrophic factor (BDNF) promotes neuronal survival and protection against neuronal damage. We addressed whether BDNF might promote survival and chemoprotection in neuroblastoma (NB) using a drug-sensitive human NB cell line. All-trans-retinoic acid (ATRA) induces a striking phenotypic differentiation of NB1643 cells, and exogenous BDNF treatment promotes survival of these differentiated cells. ATRA induces TRKB expression, and exogenous BDNF stimulates both autophosphorylation of TRKB and induction of the immediate early gene, FOS, in these cells. BDNF mRNA is expressed in NB1643 cells. Because the time course of TRKB induction closely parallels phenotypic differentiation of these cells, it seems probable that ATRA induces differentiation of NB1643 cells by establishing an autocrine loop involving BDNF and TRKB. Exogenous BDNF treatment resulted in a further increase in neurite outgrowth, which again suggests that an autocrine loop is involved in differentiation of NB1643 cells in response to ATRA. We then tested whether BDNF might afford drug resistance in NB and found that BDNF does indeed protect in this NB model against cisplatin, a DNA-damaging agent actually used in the treatment of NB.

Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Molecular Cancer TherapeuticsHome page
Z. Li, F. Tan, and C. J. Thiele
Inactivation of glycogen synthase kinase-3 contributes to brain-derived neutrophic factor/TrkB-induced resistance to chemotherapy in neuroblastoma cells
Mol. Cancer Ther., December 1, 2007; 6(12): 3113 - 3121.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. Hecht, J. H. Schulte, A. Eggert, J. Wilting, and L. Schweigerer
The neurotrophin receptor TrkB cooperates with c-Met in enhancing neuroblastoma invasiveness
Carcinogenesis, December 1, 2005; 26(12): 2105 - 2115.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J.-F. Lavoie, L. LeSauteur, J. Kohn, J. Wong, O. Furtoss, C. J. Thiele, F. D. Miller, and D. R. Kaplan
TrkA Induces Apoptosis of Neuroblastoma Cells and Does So via a p53-dependent Mechanism
J. Biol. Chem., August 12, 2005; 280(32): 29199 - 29207.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
Y. Liu, M. Encinas, J. X. Comella, M. Aldea, and C. Gallego
Basic Helix-Loop-Helix Proteins Bind to TrkB and p21Cip1 Promoters Linking Differentiation and Cell Cycle Arrest in Neuroblastoma Cells
Mol. Cell. Biol., April 1, 2004; 24(7): 2662 - 2672.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. Ho, A. Eggert, T. Hishiki, J. E. Minturn, N. Ikegaki, P. Foster, A. M. Camoratto, A. E. Evans, and G. M. Brodeur
Resistance to Chemotherapy Mediated by TrkB in Neuroblastomas
Cancer Res., November 15, 2002; 62(22): 6462 - 6466.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Jaboin, C. J. Kim, D. R. Kaplan, and C. J. Thiele
Brain-derived Neurotrophic Factor Activation of TrkB Protects Neuroblastoma Cells from Chemotherapy-induced Apoptosis via Phosphatidylinositol 3'-Kinase Pathway
Cancer Res., November 15, 2002; 62(22): 6756 - 6763.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Eggert, M. A. Grotzer, N. Ikegaki, X.-g. Liu, A. E. Evans, and G. M. Brodeur
Expression of the Neurotrophin Receptor TrkA Down-Regulates Expression and Function of Angiogenic Stimulators in SH-SY5Y Neuroblastoma Cells
Cancer Res., March 1, 2002; 62(6): 1802 - 1808.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. Sajithlal, H. Huttunen, H. Rauvala, and G. Munch
Receptor for Advanced Glycation End Products Plays a More Important Role in Cellular Survival than in Neurite Outgrowth during Retinoic Acid-induced Differentiation of Neuroblastoma Cells
J. Biol. Chem., February 22, 2002; 277(9): 6888 - 6897.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. Eggert, M. A. Grotzer, N. Ikegaki, H. Zhao, A. Cnaan, G. M. Brodeur, and A. E. Evans
Expression of the Neurotrophin Receptor TrkB Is Associated With Unfavorable Outcome in Wilms' Tumor
J. Clin. Oncol., February 1, 2001; 19(3): 689 - 696.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.